Physiologically-based pharmacokinetic (PBPK) model predicted versus observed effect of Child Pugh mild and moderate hepatic impairment on betrixaban pharmacokinetics
Event:
ESC Congress 2018
Topic:
Anticoagulants
Session:
Optimal surrogate endpoints of drug response